Literature DB >> 10459342

Novel chromosome 16 abnormality--der(16)del(16) (q13)t(16;21)(p11.2;q22)--associated with acute myeloid leukemia.

P Sharma1, N Watson, L Robson, J Gallo, A Smith.   

Abstract

Inversion of chromosome 16 is a common feature of acute myeloid leukemia (AML) M4, while t(16;21), although also associated with AML, appears to be a separate entity. We present a patient with myelodysplastic syndrome (MDS) who transformed to AML-M1. The karyotype was normal at diagnosis; at 15 months, hematological evidence of transformation was present, and repeat cytogenetics showed a novel rearrangement of one chromosome 16. Two breaks had occurred; one in the short arm at 16p11, with translocation of the segment distal to this onto chromosome 21q, and the other in the long arm at 16q22 with subsequent deletion of the segment from 16q22-->qter. Fluorescence in situ hybridization (FISH) confirmed the abnormalities detected by cytogenetics and excluded involvement of the AML1 gene on 21q22. While the 16q22 breakpoint was at the usual site for the inv(16), the 16p11 was not. The patient is more characteristic of t(16;21) than inv(16), and adds to the spectrum of chromosome 16 abnormalities in AML.

Entities:  

Mesh:

Year:  1999        PMID: 10459342     DOI: 10.1016/s0165-4608(99)00008-4

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  2 in total

1.  Independent intrachromosomal recombination events underlie the pericentric inversions of chimpanzee and gorilla chromosomes homologous to human chromosome 16.

Authors:  Violaine Goidts; Justyna M Szamalek; Pieter J de Jong; David N Cooper; Nadia Chuzhanova; Horst Hameister; Hildegard Kehrer-Sawatzki
Journal:  Genome Res       Date:  2005-09       Impact factor: 9.043

Review 2.  TLS/FUS-ERG fusion gene in acute leukemia and myelodysplastic syndrome evolved to acute leukemia: report of six cases and a literature review.

Authors:  Heyang Zhang; Qianru Zhan; Xiaoxue Wang; Feng Gao; Jinxiang Yu; Jing Wang; Wei Fu; Pingping Wang; Xin Wei; Lijun Zhang
Journal:  Ann Hematol       Date:  2022-10-01       Impact factor: 4.030

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.